Viewing StudyNCT06437223



Ignite Creation Date: 2024-06-16 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06437223
Status: RECRUITING
Last Update Posted: 2024-05-31
First Post: 2024-05-16

Brief Title: Study of Xiflam Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID LC
Sponsor: Inflammx Therapeutics Inc
Organization: Inflammx Therapeutics Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-03-12
Start Date Type: ACTUAL
Primary Completion Date: 2025-03
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-06
Completion Date Type: ESTIMATED
First Submit Date: 2024-05-16
First Submit QC Date: May 29 2024
Study First Post Date: 2024-05-31
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-29
Last Update Post Date: 2024-05-31
Last Update Post Date Type: ACTUAL